Philippe Laffont’s ResMed RMD Stock Holding History

Philippe Laffont’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-473,179	Closed	-$116M	–	91
2024 Q3	$116M	Buy	+473,179	New	+$106M	0.43%	39

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Philippe Laffont's RMD Position: Q4 2024 in Review

Philippe Laffont sold out of ResMed (RMD) in Q4 2024, closing a stake of 473,179 shares — an estimated $116M sold.

Philippe Laffont first reported a position in RMD in Q3 2024 and held it in 1 quarter. The position peaked at $116M in Q3 2024. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

Philippe Laffont reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
Philippe Laffont sold 473,179 ResMed shares in Q4 2024, an estimated $116M.
Philippe Laffont first reported a position in ResMed in Q3 2024 and held it in 1 quarter.
Philippe Laffont's ResMed position peaked at $116M in Q3 2024.
871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Coatue Management's 13F filing for Q4 2024, filed 14 Feb 2025.